A GPX4-targeted photosensitizer to reverse hypoxia-induced inhibition of ferroptosis for non-small cell lung cancer therapy

Ferroptosis therapy gradually becomes a new strategy for the treatment of non-small cell lung cancer (NSCLC) because of its active iron metabolism. Because hypoxic microenvironment in NSCLC inhibits ferroptosis heavily,...